Inspire Medical Systems (INSP) Receivables (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Receivables data on file, last reported at $105.1 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 13.45% year-over-year to $105.1 million; the trailing twelve-month figure through Mar 2026 stood at $105.1 million (up 13.45% YoY), and the FY2025 full-year result was $119.7 million, up 28.61% from the prior year.
• Receivables declined to $105.1 million in Q1 2026, from $119.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $137.7 million in Q2 2025 to a low of $34.5 million in Q1 2022.
• A 5-year average of $80.4 million and a median of $79.7 million in 2024 frame the typical range for Receivables.
• Across the five-year window, Receivables jumped 81.81% in 2022 and grew 3.54% in 2024, its largest moves.
• Tracing INSP's Receivables over 5 years: stood at $61.2 million in 2022, then soared by 46.8% to $89.9 million in 2023, then increased by 3.54% to $93.1 million in 2024, then gained by 28.61% to $119.7 million in 2025, then decreased by 12.2% to $105.1 million in 2026.
• Business Quant data shows INSP's Receivables at $105.1 million in Q1 2026, $119.7 million in Q4 2025, and $108.0 million in Q3 2025.